C16 Biosciences logo

C16 Biosciences

C16 Biosciences is a biotechnology company making alternatives to palm oil founded in 2018 by Shara Ticku, David Heller and Harry McNamara.

4

Funding Rounds

$44.0m

Money raised

Overview

C16 Biosciences is a biotechnology company making alternatives to palm oil founded in 2018 by Shara Ticku, David Heller and Harry McNamara.

Funding series

Funding Series Analysis

The company C16 Biosciences has raised a total of $20m in funding over 4 rounds.

Key Insights:

  • C16 Biosciences , March 2020: $20m
  • C16 Biosciences Series A round, March 2020: $20m
  • C16 Biosciences, Inc. funding round, November 2018: $4m
C16 Biosciences logo
C16 Biosciences , March 2020 $20m
C16 Biosciences logo
C16 Biosciences Series A round, March 2020 $20m
C16 Biosciences logo
C16 Biosciences, Inc. funding round, November 2018 $4m

Industries

C16 Biosciences is active in the following industries:
  • Plant-based oils
  • Fermentation
  • Alternative proteins
  • Palm oil
  • Plant-based products
  • Food technology
  • Biotechnology
  • Biology
  • Synthetic biology
  • Technology